Edition:
India

Kitov Pharmaceuticals Holdings Ltd (KTOV.OQ)

KTOV.OQ on NASDAQ Stock Exchange Capital Market

2.35USD
2:29am IST
Change (% chg)

$-0.01 (-0.42%)
Prev Close
$2.36
Open
$2.39
Day's High
$2.39
Day's Low
$2.31
Volume
2,151
Avg. Vol
72,080
52-wk High
$3.41
52-wk Low
$1.27

Chart for

About

Kitov Pharmaceuticals Holdings Ltd is an Israel-based company that develops non-steroidal anti-inflammatory drugs that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.

Overall

No Ratios Available.

Financials

BRIEF-Kitov pharmaceuticals announces receipt of FDA's favorable response to NT219's pre-ind meeting package

* Kitov Pharmaceuticals announces receipt of FDA's favorable response to NT219's pre-ind meeting package

01 Nov 2017

BRIEF-Kitov Pharmaceuticals announces phase III/IV clinical trial for KIT-302 successfully meets primary endpoint

* Kitov pharmaceuticals announces phase iii/iv clinical trial for kit-302 successfully meets primary endpoint, and also demonstrates drug candidate improves renal function

27 Oct 2017

BRIEF-Kitov boosts ownership in Tyrnovo and Oncology platform

* Kitov boosts ownership in Tyrnovo and Oncology platform through exchange of shares for stock

06 Oct 2017

BRIEF-Kitov posts filing by FDA of New Drug Application for KIT-302

* Kitov announces filing by FDA of New Drug Application for KIT-302

02 Oct 2017

BRIEF-Kitov submits new drug application to FDA for KIT-302

* Says ‍company expects that within 60 days FDA will determine whether NDA is complete and acceptable for filing​

01 Aug 2017

Earnings vs. Estimates